IMARC Engineering Enhances GMP Readiness Assessment Through GMP Compliance Audit Services

Good Manufacturing Practice compliance in India has moved from a paperwork exercise to a business-critical priority. Regulatory tightening under the revised Schedule M framework has raised the bar for infrastructure, documentation, and quality systems across pharmaceutical, food, and healthcare manufacturing.

A GMP readiness assessment finds the gaps before a regulator, buyer, or certification body does. IMARC Engineering's GMP Compliance Audit Services convert scattered documentation and ad-hoc practices into an audit-ready quality system, well before a formal inspection date is set.

Why GMP Compliance Has Become Non-Negotiable in India:

• Under the revised Schedule M notified in December 2023, large manufacturers with turnover above ₹250 crore were required to comply by June 2024, while MSME units were given an extended deadline of December 31, 2025.

• Of an estimated 8,500 pharmaceutical MSME units in India, around 2,000 already hold WHO-GMP certification.

• Of the remaining roughly 6,500 units, only about 1,700 close to 26% had submitted Form A gap-analysis plans by the extended deadline, leaving nearly 4,300 units exposed to non-compliance action.

• Industry bodies estimate that facility upgradation to meet revised norms requires capital infusion of at least ₹2 crore per unit, covering infrastructure, retrofitting, and staff training.

• India's pharmaceutical exports rose to around US$31 billion in FY2025-26 from close to US$14 billion in FY2014-15, with more than 60% of that volume headed to highly regulated markets where GMP status is a market-access precondition.

• India now has over 10,500 pharmaceutical manufacturing units and more than 60,000 generic brands, giving buyers and regulators a wide base to compare compliance standards against.

The regulatory direction is clear: GMP is shifting from a certificate on file to a continuously verified operating standard, and manufacturers who wait for an inspection notice to start preparing are already behind.

Connect with IMARC Engineering to assess your GMP readiness and strengthen compliance before regulatory inspections: https://www.imarcengineering.com/contact?service=sop-compliance-and-mock-inspections

The Cost of an Unprepared GMP Audit:

• Production stoppage: A failed or partially failed audit can trigger a stop-production order until corrective actions are verified, disrupting committed delivery schedules.

• Licence risk: Persistent non-compliance with factory licence and environmental consent conditions can lead to licence suspension or cancellation.

• Lost export access: Regulated export markets increasingly require current, verifiable GMP status; a lapse can freeze shipments mid-contract.

• Remediation cost escalation: Gaps found during a live regulatory audit are far costlier to fix under time pressure than the same gaps found during a planned internal assessment.

• Client and buyer disqualification: OEMs and brand owners routinely exclude manufacturers who cannot produce current audit evidence, regardless of product quality.

• Repeat-audit cycles: An unresolved observation from one audit often triggers closer scrutiny in the next, extending the compliance burden over multiple cycles.

What a Comprehensive GMP Readiness Assessment Covers:

A credible GMP readiness assessment examines the full quality ecosystem, not just the production floor.

1. Pharmaceutical Quality System and Documentation

• Standard operating procedures for production, testing, and change control

• Batch manufacturing and packaging records against actual practice

• Document control, version history, and archival discipline

• Product quality review cycles and trend analysis

2. Facility, Utility, and Equipment Qualification

• Design, installation, operational, and performance qualification status

• HVAC, water systems, and compressed air validation records

• Equipment calibration schedules and maintenance logs

• Cleanroom classification and environmental monitoring data

3. Quality Risk Management

• Risk assessment methodology applied to processes and materials

• Change control linked to risk evaluation, not just approval sign-off

• Supplier and raw material qualification records

• Contamination and cross-contamination control measures

4. Personnel Training and Hygiene Practices

• Training records mapped to actual job functions

• Gowning and hygiene compliance on the shop floor

• Competency verification for critical process steps

• Visitor and contractor access controls

5. Deviation and CAPA Management

• Root-cause analysis quality on closed deviations

• CAPA effectiveness checks, not just closure dates

• Recurring deviation patterns across product lines

• Escalation protocols for critical quality events

6. Regulatory and Documentation Readiness

• Factory licence and CPCB environmental consent validity

• Product-specific approvals: CDSCO, FSSAI, BIS, or export-market equivalents

• Readiness of the site master file and quality manual

• Historical inspection observations and their closure status

How IMARC Engineering Conducts GMP Compliance Audits:

• Gap assessment: Benchmarking current practices against revised Schedule M and applicable WHO-GMP or sector-specific standards to identify priority gaps.

• Documentation review: Line-by-line review of SOPs, batch records, validation protocols, and training files against actual operating practice.

• On-site audit: Physical inspection of production areas, utilities, warehousing, and environmental controls to verify what documentation claims.

• CAPA roadmap: A prioritised, time-bound corrective action plan sequenced by regulatory risk and remediation cost.

• Mock regulatory audit: A simulated inspection conducted the way a CDSCO or WHO-GMP assessor would run it, surfacing weak points before the real event.

• Post-remediation verification: A follow-up audit confirming that corrective actions are implemented and sustained, not just documented.

IMARC Engineering applies this methodology across pharmaceuticals, nutraceuticals, food processing, medical devices, and allied manufacturing sectors, where GMP expectations differ in detail but share the same underlying discipline of evidence over assumption.

Explore Our Service: https://www.imarcengineering.com/services/sop-compliance-and-mock-inspections

Common Gaps IMARC Engineering Identifies During Readiness Assessments:

• SOPs that describe an idealised process rather than the one actually followed on the floor

• Calibration and preventive maintenance schedules that have slipped without formal deviation records

• Training records that exist but are not mapped to the specific tasks personnel perform

• CAPA files closed on paperwork completion rather than verified effectiveness

• Environmental monitoring data collected but not trended for early warning signals

• Subcontracted or outsourced steps that are not disclosed in the quality documentation

Conclusion:

GMP compliance in India has entered a phase where documentation alone no longer satisfies regulators, buyers, or export markets. With MSME compliance deadlines under revised Schedule M largely exhausted and a meaningful share of manufacturers still short of the required standard, the manufacturers who invest in a structured readiness assessment now are the ones who avoid production stoppages, licence risk, and lost contracts later.

Through GMP readiness assessments, documentation audits, on-site inspections, and CAPA implementation support, IMARC Engineering helps manufacturers convert GMP compliance from a recurring source of risk into a demonstrable operating strength.

As regulatory expectations continue to evolve across India's pharmaceutical and healthcare manufacturing sectors, GMP readiness assessments are becoming an essential element of operational excellence rather than simply a pre-audit exercise. Organizations that continuously evaluate and strengthen their quality systems will be better positioned to maintain compliance, support exports, and improve long-term manufacturing performance.

About Us:

IMARC Engineering is a leading provider of GMP Compliance Audit and GMP Readiness Assessment services for pharmaceutical, nutraceutical, food, and medical device manufacturers across India. The company helps manufacturers evaluate quality systems, identify compliance gaps, strengthen documentation, and achieve readiness for Schedule M, WHO-GMP, CDSCO, and customer audits through structured assessments, on-site inspections, CAPA planning, and regulatory compliance advisory.

Contact Us:

IMARC Engineering
Phone: +91-120-433-0800
Email: sales@imarcengineering.com
India: C-130, Sector 2, Noida, Uttar Pradesh 201301
LinkedIn: https://www.linkedin.com/showcase/imarc-engineering/

This release was published on openPR.